- Home
- Clinical Trials
CKD & High Blood Pressure Studies Sydney DH 69-03
Chronic Kidney Disease & High Blood Pressure Studies
Darlinghurst Sydney
Please note that this study has now closed. However, we encourage you to pre-register your interest for future CKD studies here.
Description
What to expect
Study details
Ages
18 years or older
Duration
Up to 2 years, with 4 clinic visits in the first 16 weeks, followed by appointments approximately every 4 months
Compensation
Participants will be compensated a reasonable travel cost
Eligibility Criteria
You may qualify for this study if you:
- Are 18 years or older
- Have chronic kidney disease (CKD) with reduced kidney function
- Have high blood pressure, even while taking medication
- Taking a regular dose of a blood pressure medicine called an ACE inhibitor or an ARB (medications ending in ‘pril’ or ‘tan’. E.g., perindopril, ramipril, candesartan, olmesartan, telmisartan)
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to function. Because the kidneys help filter waste, balance fluids, and regulate blood pressure, even mild to moderate kidney damage can have a serious impact on daily life.
For many people living with CKD, the effects go beyond lab results. Fatigue, swelling, changes in urination, and ongoing high blood pressure are common and can make it difficult to maintain the energy needed for work, family, and social activities. Some people experience nausea, poor appetite, or difficulty concentrating as the disease progresses.
Many current treatments manage symptoms but don’t significantly slow disease progression. That’s why new treatment approaches are urgently needed.
This study is exploring whether combining two medications could help protect kidney function, reduce blood pressure and long-term health risks, and ultimately improve quality of life for people living with CKD.
The study is investigating whether an investigational medication that works to block harmful effects of certain hormones in the body, when combined with an approved medication that helps protect the kidneys, can:
- Slow the decline in kidney function
- Reduce the risk of kidney failure
- Lower the risk of cardiovascular complications like heart attack or stroke
- Improve overall health outcomes for people with CKD and hypertension
What to expect
You will visit the clinic regularly for health assessments, including blood pressure monitoring, kidney function tests, and general checkups. Your safety and well-being will be closely monitored by a professional clinical team.
Why join this clinical research study?
- Gain early access to a new potential treatment at no cost
- Help researchers understand how to better treat and slow progression of CKD
- Learn to better manage your condition
- Receive health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future CKD studies here.